We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Oramed Pharmaceuticals Inc | NASDAQ:ORMP | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.005 | 0.21% | 2.35 | 2.17 | 2.41 | 2.45 | 2.35 | 2.38 | 64,697 | 23:00:01 |
ORAMED PHARMACEUTICALS INC.
|
(Exact name of registrant as specified in its charter)
|
DELAWARE
|
001-35813
|
98-0376008
|
(State or Other Jurisdiction
|
(Commission
|
(IRS Employer
|
of Incorporation)
|
File Number)
|
Identification No.)
|
Hi-Tech Park 2/4 Givat Ram, PO Box 39098, Jerusalem, Israel
|
91390
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.
|
(d)
|
Exhibits.
|
99.1
|
Presentation
|
|
99.2
|
Press release issued by Oramed on April 24, 2014
|
ORAMED PHARMACEUTICALS INC.
|
|||
By:
|
/s/ Nadav Kidron | ||
Name: Nadav Kidron | |||
Title: President and CEO
|
|||
1 Year Oramed Pharmaceuticals Chart |
1 Month Oramed Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions